May 4 (Reuters) - Corbus Pharmaceuticals Holdings Inc's experimental drug for cystic fibrosis, a rare lung-scarring disease, could be a real money spinner and pose a challenge to rival Vertex Pharmaceuticals Inc's successful treatment, Kalydeco.
May 4 (Reuters) - AcelRx Pharmaceuticals Inc said a division of the U.S. Food and Drug Administration had rejected the company's request for a meeting to discuss the need for an additional trial of...
FRANKFURT, May 4 (Reuters) - German drugmaker Bayer secured the rights to an experimental anti-blood-clotting drug in a deal with California-based Isis Pharmaceuticals to bolster its cardiovascular business led by blockbuster pill Xarelto.
* Envarsus XR demonstrates improved pharmacokinetic profile in African-American transplant recipients
continue to think the company's growth by acquisition strategy, such as its recent $5.2 billion purchase of NPS Pharmaceuticals reinforces Shire's narrow economic moat, as the deal adds new drugs to its growing rare disease portfolio and leverages
I developed a strategy based on buying high dividend individual stocks. 70% of the portfolio is in large cap telecom, drug companies , utilities, oil and gas adn consumer staples. 30% is in higher yielding REIT and BDC. I generate a 6.0-6.5
April 29 (Reuters) - Draft U.S. legislation released on Wednesday could make it easier for drug companies to win Food and Drug Administration approval of products for new uses.
April 29 (Reuters) - Ariad Pharmaceuticals Inc said Chief Executive Harvey Berger would retire as part of a deal to settle a proxy battle with its largest shareholder Sarissa Capital Management.
April 29 (Reuters) - Drugmaker Valeant Pharmaceuticals International Inc raised its earnings and sales forecasts for the year on Wednesday and said its chief financial officer will step down.
April 29 (Reuters) - Sarissa Capital Management LP said Ariad Pharmaceuticals Inc's Harvey Berger would retire as CEO as part of a deal to settle the hedge funds's proxy battle with the drugmaker.